Redenlab awarded $2.5M to scale AI-driven speech biomarkers for dementia detection
Receiving the CUREator+ Dementia & Cognitive Decline funding marks a meaningful milestone in our journey to transform how…
dementia
Latest content
ARIAS: Zooming in on eye-based biomarkers for Alzheimer’s
Scientists are turning to retinas as a potential screening target for early signs of Alzheimer’s, an incurable neurodegenerative…
Redenlab strengthens its reach in linguistic/language analytics with appointment of eminent neuroscientist Prof Adolfo Garcia
Dr Garcia joins the Redenlab science team to drive its language analytics pipeline for cognitive-linguistic disorders like fronto-temporal…
